BioNTech, the German pharmaceutical company that developed a successful corona vaccine together with Pfizer, has made a net profit of 10.3 billion euros in 2021. The turnover amounted to almost 19 billion, the company from Mainz announced on Wednesday. For the current financial year, BioNtech expects a turnover from its corona vaccine between 13 and 17 billion euros.
ttn-3
Vaccine company BioNTech makes 10.3 billion euros profit
